Cavanaugh Sarah - Insider Non-Derivative Transactions at Celldex Therapeutics, Inc. (CLDX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 30, 2024, Cavanaugh Sarah's relationship to Celldex Therapeutics, Inc. (CLDX) is Officer (SVP OF CORP AFFAIRS & ADMIN.), and currently has 22,713 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CLDX insiders.
Data Source: SEC.
Cavanaugh Sarah - Insider Non-Derivative Transactions at CLDX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 31, 2024 | Sell -- (Common Stock) | 20853 | 33.73 | 1860 |
| May 31, 2024 | M -- (Common Stock) | 10750 | 2.78 | 12610 |
| May 31, 2024 | M -- (Common Stock) | 10103 | 9.02 | 22713 |